羟乙基淀粉注射液联合纤溶酶治疗急性脑梗死的疗效探究

The effect of hydroxyethyl starch injection combined with plasmin in treatment of acute cerebral infarction

目的对应用纤溶酶与羟乙基淀粉注射液联合对患有急性脑梗死的患者进行治疗的临床效果进行研究分析。方法抽取88例患有急性脑梗死的患者,将其分为对照组和治疗组,平均每组44例。采用纤溶酶对对照组患者进行治疗;采用纤溶酶与羟乙基淀粉注射液联合对治疗组患者进行治疗。结果治疗组患者急性脑梗死症状治疗效果明显优于对照组;脑梗死病情改善时间和临床实际用药时间明显短于对照组;治疗前后患者血液流变学指标的改善幅度明显大于对照组;两组治疗期间未观察到任何药物不良反应。结论应用纤溶酶与羟乙基淀粉注射液联合对患有急性脑梗死的患者进行治疗的临床效果非常明显。

Objective To investigate the clinical therapeutic effect plasmin and hydroxyethyl starch injection in treat- ment of acute cerebral infarction. Methods Eighty-eight patients suffering from acute cerebral infarction were divided into control group and treatment group, 44 cases in each group. The patients in the control group were treated with plasmin; patients in the treatment group were treated with plasmin and hydroxyethyl starch injection. Results The effect of treatment group was obviously superior to the control group; cerebral infarction improved time and clinical actual medication time was significantly shorter than that in the control group; before and after the treatment, blood rheology index improved significantly greater than the control group; there was no adverse drug reaction in two groups. Conclusion The effect of hydroxyethyl starch injection combined with plasmin in treatment of acute cerebral infarction is very obvious.